Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
08/28/2003 | WO2003070747A2 Insulin and igf-1 receptor agonists and antagonists |
08/28/2003 | WO2003070744A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
08/28/2003 | WO2003070738A2 Topiramate salts and compositions comprising and methods of making and using the same |
08/28/2003 | WO2003070731A2 Azabicyclic compounds for the treatment of disease |
08/28/2003 | WO2003070730A1 Pyrrolopyrimidine derivative |
08/28/2003 | WO2003070729A1 Pyrrolopyrimidine derivatives |
08/28/2003 | WO2003070728A2 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders |
08/28/2003 | WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer |
08/28/2003 | WO2003070726A1 Pyranones useful as atm inhibitors |
08/28/2003 | WO2003070717A1 Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
08/28/2003 | WO2003070716A1 Vitamin d3 derivatives and remedies using the same |
08/28/2003 | WO2003070711A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
08/28/2003 | WO2003070709A1 Novel phenylalanine derivative |
08/28/2003 | WO2003070707A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
08/28/2003 | WO2003070701A2 Syntheses of quinazolinones |
08/28/2003 | WO2003070697A1 Method of assaying activity of binding to vitamin d3 receptor using fluorescence polarization |
08/28/2003 | WO2003070691A1 N-hydroxycarboxamide derivative |
08/28/2003 | WO2003070690A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
08/28/2003 | WO2003070686A1 Substituted phenylalkanoic acid derivative and use thereof |
08/28/2003 | WO2003070675A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
08/28/2003 | WO2003070665A2 Desolvating solvates of atorvastatin hemi-calcium |
08/28/2003 | WO2003070279A1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient |
08/28/2003 | WO2003070276A1 A preparation and method for weight reduction |
08/28/2003 | WO2003070264A1 Anion exchange resin adsorbed fraction, immunopotentiator and promoter for recovery from loaded stress originating in matsutake mushroom |
08/28/2003 | WO2003070263A1 Process for producing hydrophobic glycyrrhiza extract with high qualities |
08/28/2003 | WO2003070260A1 A photoprotective orally administrable composition for skin |
08/28/2003 | WO2003070256A1 Hyaluronic acid mediated adenoviral transduction |
08/28/2003 | WO2003070251A1 Pharmaceutical combinations of cox-2 inhibitors and opiates |
08/28/2003 | WO2003070245A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists |
08/28/2003 | WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
08/28/2003 | WO2003070235A1 Medicinal compositions for inhibiting tryptase |
08/28/2003 | WO2003070233A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
08/28/2003 | WO2003070221A1 Chemosensitizing with liposomes containing oligonucleotides |
08/28/2003 | WO2003070220A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
08/28/2003 | WO2003070204A2 Lipase inhibiting composition |
08/28/2003 | WO2003070188A2 Method of treating trx mediated diseases |
08/28/2003 | WO2003070182A2 Sodium channel blockers |
08/28/2003 | WO2003070180A2 Compositions and methods for delivery of skin cosmeceuticals |
08/28/2003 | WO2003070171A2 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
08/28/2003 | WO2003070166A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods |
08/28/2003 | WO2003070019A1 Pet food composition for skin photoprotection |
08/28/2003 | WO2003049698A3 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
08/28/2003 | WO2003041683A3 Orodispersible tablets containing fexofenadine |
08/28/2003 | WO2003037384A3 Polymer conjugates of protein kinase c inhibitors |
08/28/2003 | WO2003031447A3 Pyrimidine derivatives |
08/28/2003 | WO2003029217A3 Pyridinic sulfonamide derivatives, method of production and use thereof |
08/28/2003 | WO2003028840A3 Combined compositions and methods for tumor vasculature coagulation and treatment |
08/28/2003 | WO2003028641A3 Mch receptor antagonists |
08/28/2003 | WO2003027116A3 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
08/28/2003 | WO2003020202A3 Method for reducing hypertension and heart failure |
08/28/2003 | WO2003017998B1 Platinum complexes and their use in cancer treatment |
08/28/2003 | WO2003016522A3 Methods and compounds for the targeting of protein to exosomes |
08/28/2003 | WO2003016335A3 Irreversible cysteine protease inhibitors of legumain |
08/28/2003 | WO2003014321A3 Compositions and methods for modulation of darpp-32 phosphorylation |
08/28/2003 | WO2003014161A3 Antigen binding domains from fish |
08/28/2003 | WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace |
08/28/2003 | WO2003004007A3 Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (ibd) |
08/28/2003 | WO2003002559A3 Piperidine compounds for use as orexin receptor antagonist |
08/28/2003 | WO2003002105A3 Use of tyrosine kinase inhibitors for treating bone loss |
08/28/2003 | WO2002102359A3 Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity |
08/28/2003 | WO2002094192A3 Antibodies against tumor necrosis factor delta (april) |
08/28/2003 | WO2002083720A3 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
08/28/2003 | WO2002081521A3 Osteoprotegerin in milk |
08/28/2003 | WO2002074337A8 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
08/28/2003 | WO2002074048A8 P-glycoproteins and uses thereof |
08/28/2003 | WO2002062369A3 Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer |
08/28/2003 | WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha |
08/28/2003 | WO2002040451A3 Lactam compound |
08/28/2003 | WO2002040005A3 Blockade of sodium channels by phenol derivatives |
08/28/2003 | WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof |
08/28/2003 | WO2002034940A3 Methods for screening compounds that modulate lipid metabolism |
08/28/2003 | WO2002034922A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
08/28/2003 | WO2002028430A3 Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid |
08/28/2003 | WO2002015885A3 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
08/28/2003 | WO2002012326A3 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
08/28/2003 | WO2002008399A3 Human kinases |
08/28/2003 | WO2002002780A3 Human serine-threonine kinase |
08/28/2003 | WO2002000839A3 Statement as to federally sponsored research |
08/28/2003 | WO2001095859A3 Novel heterocyclic analogs of diphenylethylene compounds |
08/28/2003 | WO2001085147A3 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF |
08/28/2003 | US20030162970 For use as anti-inflammatory agents |
08/28/2003 | US20030162969 Process and intermediates for pyridazinone antidiabetic agents |
08/28/2003 | US20030162967 Having antithrombotic effect; fortherapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses; reversible inhibitors of blood clotting enzymes factor Xa and/or factor VIIa |
08/28/2003 | US20030162964 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
08/28/2003 | US20030162946 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
08/28/2003 | US20030162837 Carboxyfullerenes and methods of use thereof |
08/28/2003 | US20030162819 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
08/28/2003 | US20030162813 Heterocyclic nitrogen comppounds such as 4-(5-methyl-3-phenyl-isoxazol-1-yl)benzenesulfonamide, used as non-steroidal antiinflammatory agents or antiarthritic agents; cyclooxygenase inhibitors |
08/28/2003 | US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain |
08/28/2003 | US20030162807 Compositions and methods for treating osteoporosis and lowering cholesterol |
08/28/2003 | US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders |
08/28/2003 | US20030162801 Tricyclic compounds and their uses |
08/28/2003 | US20030162800 Nitrogen compounds such as 10-Butyl-8-chloro-10-(trifluoro methyl)-5,10-dihydropyrimido(5,4-b)quinolin-4(3H)-one, used as polymerase inhibitors for prophylaxis of viral diseases |
08/28/2003 | US20030162799 Squaric acid derivatives |
08/28/2003 | US20030162796 Pharmaceutical composition for the treatment of disorders of non-human mammals |
08/28/2003 | US20030162791 Phenylpiperazines |
08/28/2003 | US20030162784 Pyridazinone aldose reductase inhibitors |
08/28/2003 | US20030162782 Treating a patient suffering from neuropathy with sidenafil, free of 5-(3-pyridyl)pyrazoleo(4,3-d)pyrimidine-7-one, 2-(3-pyridyl)-4a,5-dihydroimidazo(5,1-f)(1,2,4)triazine-4(3H)-one or 2-phenylpurine-6-one, all are substituted |
08/28/2003 | US20030162780 Administering to a patient with a disease treatable with a muscarinic receptor antagonist a 1,2,3,4-tetrahydro-naphthalene-2-yl-alkylaminoalkyl-piperidine derivative |
08/28/2003 | US20030162779 4-oxo-4H-thiazole derivative for treating or preventing neurodegenerative disorders |